Symposium: Ovarian tumors of borderline malignancy

International Journal of Gynecological Pathology

Volumn 15, Issue 4, 1996, Pages 281-302

  Silva, Elvio G ^a   Kurman, Robert J ^b   Russell, Peter ^d   Scully, Robert E ^c  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

Borderline tumor; Carcinoma; Mucinous; Ovary; Pseudomyxoma; Serous

Indexed keywords

BENIGN TUMOR; CANCER DIAGNOSIS; CANCER INVASION; CONFERENCE PAPER; DIFFERENTIAL DIAGNOSIS; FEMALE; HISTOPATHOLOGY; HUMAN; MALIGNANT NEOPLASTIC DISEASE; OVARY TUMOR; PRIORITY JOURNAL;

EID: 0029812780     PISSN: 02771691     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004347-199610000-00001     Document Type: Conference Paper

References (62)

1. Kurman RJ, Trimble CL. The behavior of serous tumor of low malignant potential: are they ever malignant? Int J Gynecol Pathol 1993;12:120-7.
2. Russell P. Ovarian epithelial tumours with atypical proliferation. In: Lowe D, Fox H, eds. Advances in gynaecologic pathology, Edinburgh: Churchill Livingstone, 1992:299-320.
3. Silva E, Tornos C, Zhuang A, Merino M, Gershenson D. Tumor recurrence in stage I ovarian serous low malignant potential neoplasms [Abstract]. Mod Pathol 1996;9:98A.
4. Hart WR, Norris HJ. Borderline and malignant tumors of the ovary. Cancer 1973;31:1031-45.
5. Watkin W, Silva EG, Gershenson DM. Mucinous carcinoma of the ovary: Pathologic prognostic factors. Cancer 1992;69: 208-12.
6. Ronnett BM, Zahn CM, Kurman RJ, Kass ME, Sugarbaker PH, Shmookler BM. Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. Am J Surg Pathol 1995;19:1390-1408.
7. International Federation of Gynecology and Obstetrics. Classification and staging of malignant tumors in the female pelvis. Acta Obstet Gynec Scand 1971;50:1-7.
8. Serov SF, Scully RE, Sobin LH. Histological typing of ovarian tumours. In: International histological classification of tumours, no. 9, 1973:17.
9. Kottmeier H-L. The classification and treatment of ovarian tumours. Acta Obstet Gynecol Scand 1952;31:313-63.
10. Aure J, Hoeg K, Kolstad P. Clinical and histologic studies of ovarian carcinoma: long-term followup of 990 cases. Obstet Gynecol 1971;37:1-9.
11. Munnell EW, Taylor HC Jr. Ovarian carcinoma: a review of 200 primary and 51 secondary cases. Am J Obstet Gynecol 1949;58:943-59.
12. De Nictolis M, Montironi R, Tommasoni S, et al. Serous borderline tumors of the ovary: a clinicopathologic, immunohistochemical, and quantitative study of 44 cases. Cancer 1992;70:152-60.
13. Drescher CW, Flint A, Hopkins MP, Roberts JA. Prognostic significance of DNA content and nuclear morphology in borderline ovarian tumors. Gynecol Oncol 1993;48:242-6.
14. Harlow BL, Fuhr JE, McDonald TW, Schwartz SM, Beuerlein FJ, Weiss NS. Flow cytometry as a prognostic indicator in women with borderline epithelial ovarian tumors. Gynecol Oncol 1993;50:305-9.
15. Kuprzjanczyk J, Bell DA, Yandell DW, Scully RE, Thor AD. p53 expression in ovarian borderline tumors and stage I carcinomas. Am J Clin Pathol 1994;102:671-6.
16. Seidman JD, Norris HJ, Griffin JL, Hitchcock CL. DNA flow cytometric analysis of serous ovarian tumors of low malignant potential. Cancer 1993;71:3947-51.
17. Seidman JD, Frishman DM, Norris HJ. Expression of the HER-2/neu proto-oncogene in serous ovarian neoplasms. Cancer 1992;70:2857-60.
18. Wertheim I, Muto MG, Welch WR, Bell DA, Berkowitz RS, Muk SC. p53 gene mutation in human borderline epithelial ovarian tumors. J Natl Cancer Inst 1994;86:1549-51.
19. Bell DA, Weinstock MA, Scully RE. Peritoneal implants of ovarian serous borderline tumors. Cancer 1988;62:2212-22.
20. Russell P. The pathological assessment of ovarian neoplasms. II: the proliferating "epithelial" tumours. Pathology 1979;11:251-82.
21. Russell P, Merkur H. Proliferating ovarian "epithelial tumours: a clinico-pathological analysis of 144 cases." Aust N Z J Obstet Gynecol 1979;19:45-51.
22. Burks RT, Sherman ME, Kurman RJ. Micropapillary serous carcinoma of the ovary: a distinctive low-grade carcinoma related to serous borderline tumors. Am J Surg Pathol 1996;20(11) (in press).
23. Seidman JD, Kurman RJ. Subclassification of serous borderline tumors of the ovary into benign and malignant types: a clinicopathologic study of 65 advanced stage cases. Am J Surg Pathol 1996;20(11) (in press).
24. Russell P. Surface epithelial-stromal tumors of the ovary. In: Kurman RJ, ed. Blaustein's pathology of the female genital tract, 4th ed. New York: Springer-Verlag, 1994:705-82.
25. Ronnett BM, Kurman RJ, Zahn CM, et al. Pseudomyxoma peritonei in women: a clinicopathologic analysis of 30 cases with emphasis on site of origin, prognosis, and relationship to ovarian mucinous tumors of low malignant potential. Hum Pathol 1995;26:509-24.
26. Young RH, Gilks CB, Scully RE. Mucinous tumors of the appendix associated with mucinous tumors of the ovary and pseudomyxoma peritonei: a clinicopathological analysis of 22 cases supporting an origin in the appendix. Am J Surg Pathol 1991;15:415-29.
27. Prayson RA, Hart WR, Petras RE. Pseudomyxoma peritonei: a clinicopathologic study of 19 cases with emphasis on site of origin and nature of associated ovarian tumors. Am J Surg Pathol 1994;19:591-603.
28. Siriaunkgul S, Robbins KM, McGowan L, Silverberg SG. Ovarian mucinous tumors of low malignant potential: a clinicopathologic study of 54 tumors of intestinal mullerian type. Int J Gynecol Pathol 1995;14:198-208.
29. Guerrieri C, Hogberg T, Wingren S, Fristedt S, Simonsen E, Boeryd B. Mucinous borderline and malignant tumors of the ovary. Cancer 1994;74:2329-40.
30. De Nictolis M, Montironi R, Tommasoni S, Valli M, Pisani E, Fabris G, Prat J. Benign, borderline, and well- differentiated malignant intestinal mucinous tumors of the ovary: a clinicopathologic, histochemical, immunohisto- chemical, and nuclear quantitative study of 57 cases. Int J Gynecol Pathol 1994;13:10-21.
31. Schildkraut JM, Thompson WD. Familial ovarian cancer: a population-based case-control study. Am J Epidemiol 1988; 128:456-66.
32. Rossing MA, Daling JR, Weiss NS, Morre DE, Self RG. Ovarian tumors in a cohort of infertile women. N Engl J Med 1994;331:771-6.
33. Taylor HC Jr. Malignant and semimalignant tumours of the ovary. Sur g Gynecol Obstet 1929;48:204-30.
34. Taylor HC Jr. Studies in the clinical and biological evolution of adenocarcinoma of the ovary. J Obstet Gynaecol Br Commons 1959;66:827-42.
35. Boring CC, Squires TS, Tong T, Montgomery S. Cancer statistics 1994. CA Cancer Clin 1994;44:7-26.
36. Scully RE. Tumors of the ovary and maldeveloped gonads. Washington DC: Armed Forces Institute of Pathology, 1979: 53-151 (AFIP fasc 16, 2nd series).
37. Lauchlan SC. Non-invasive ovarian carcinoma. Int J Gynecol Pathol 1990;9:158-69.
38. Lauchlan SC. The secondary mullerian system revisited. Int J Gynecol Pathol 1994;13:73-9.
39. Bell DA, Scully RE. Benign and borderline serous tumors of the peritoneum in women. Pathol Annu 1989;242:1-21.
40. Hart WR. Ovarian epithelial tumors of borderline malignancy (carcinomas of low malignant potential). Hum Pathol 1977;8:541-9.
41. Tavassoli FA. Serous tumor of low malignant potential with early stromal invasion (serous LMP with microinvasion). Mod Pathol 1988;1:407-14.
42. Bell DA, Scully RE. Ovarian serous borderline tumors with stromal microinvasion: a report of 21 cases. Hum Pathol 1990;21:397-403.
43. Chaitin BA, Gershenson DM, Evans HL. Mucinous tumors of the ovary: a clinicopathologic study of 70 cases. Cancer 1985;55:1958-62.
44. Sumithran E, Susil BJ, Loon L-M. The prognostic significance of grading in borderline mucinous tumors of the ovary. Hum Pathol 1988;19:15-8.
45. Scully RE, Young RH, Clement PB. Tumors of the ovary, maldeveloped gonads, fallopian tube, and broad ligament. Washington, DC: Armed Forces Institute of Pathology (Atlas of tumor pathology) (in press).
46. Katzenstein A-LA, Mazur MT, Morgan TE, Kao M-S. Proliferative serous tumors of the ovary: histological features and prognosis. Am J Surg Pathol 1978;2:339-55.
47. Tsao S-W, Mok C-H, Knapp RC, et al. Molecular genetic evidence for a unifocal origin for human serous ovarian carcinomas. Obstet Gynecol 1993;48:5-10.
48. Li S, Han H, Resnick E, Carcangiu ML, Schwartz PE, Yang-Feng TL. Advanced ovarian carcinoma: molecular evidence of unifocal origin. Gynecol Oncol 1993;51:21-5.
49. Costa MJ. Pseudomyxoma peritonei: histologic predictors of patient survival. Arch Pathol Lab Med 1994;118:1215-9.
50. Kaern J, Tropé CG, Abeler VM. A retrospective study of 370 borderline tumors of the ovary treated at the Norwegian Radium Hospital from 1970 to 1982. Cancer 1993;71:1810- 20.
51. Michael H, Sutton G, Roth LM. Ovarian carcinoma with extracellular mucin production: reassessment of "pseudomyxoma ovarii et peritonei." Int J Gynecol Pathol 1987;6: 298-312.
52. Young RH, Gilks CB, Scully RE. Pseudomyxoma peritonei [Letter to the Editor]. Am J Surg Pathol 1993;17:1068-70.
53. Kahn MA, Demopoulos RI. Mucinous ovarian tumors with pseudomyxoma peritonei: a clinicopathological study. Int J Gynecol Pathol 1992;11:15-23.
54. Seidman JD, Elsayed AM, Sobin LH, Tavassoli FA. Association of mucinous tumors of the ovary and appendix: a clinicopathologic study of 25 cases. Am J Surg Pathol 1992; 17:22-34.
55. Seidman JD, Elsayed AM, Sobin LH, Tavassoli FA. Authors' reply to the editor. Am J Surg Pathol 1993;17:1070-1.
56. Chuaqui RF, Zhuang Z, Emmert-Buck MR, et al. Genetic analysis of synchronous mucinous tumors of the ovary and appendix. Hum Pathol 1996;27:165-71.
57. Cuatrecasas M, Matias-Guiu X, Prat J. Synchronous mucinous tumors of the appendix and the ovary associated with pseudomyxoma peritonei: a clinicopathologic study of six cases with comparative analysis of c-Ki-ras mutations. Am J Surg Pathol 1996;20:739-46.
58. Nayar R, Siriaunkgul S, Robbins KM, McGowan L, Ginzan S, Silverberg SG. Microinvasion in low malignant potential tumors of the ovary. Hum Pathol 1996;27:521-7.
59. McCaughey WTE, Kirk ME, Lester W, Dardick I. Peritoneal epithelial lesions associated with proliferative serous tumours of ovary. Histopathology 1984;8:195-208.
60. Longacre TA, Kempson RL, Hendrickson MR. Well- differentiated serous neoplasms of the ovary. In: State of the art reviews: pathology. Philadelphia: Hanley & Belfus, 1992: 255-306.
61. Padberg B-C, Stegner H-E, von Sengbusch S, Arps H, Schröder S. DNA-cytophotometry and immunohistochemistry in ovarian tumours of borderline malignancy and related peritoneal lesions. Virchows Arch A Pathol Anat 1992;421:497-503.
62. Rutgers JL, Scully RE. Ovarian mullerian mucinous papillary cystadenomas of borderline malignancy: a clinicopathologic analysis. Cancer 1988;61:340-8.